Biofilm treatment for Visual Snow Syndrome involves targeted antimicrobial and anti-inflammatory interventions to disrupt pathological neurological biofilm formations, potentially affecting neuroinflammatory pathways. The primary mechanism focuses on reducing microglial activation and neuronal membrane disruption through specialized pharmaceutical agents that can penetrate the blood-brain barrier and modulate neurological inflammatory responses.